{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T21:34:33Z","timestamp":1780349673355,"version":"3.54.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s00401-009-0530-3","type":"journal-article","created":{"date-parts":[[2009,4,9]],"date-time":"2009-04-09T07:51:35Z","timestamp":1239263495000},"page":"505-517","source":"Crossref","is-referenced-by-count":41,"title":["A fibril-specific, conformation-dependent antibody recognizes a subset of A\u03b2 plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain"],"prefix":"10.1007","volume":"118","author":[{"given":"Floyd","family":"Sarsoza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy","family":"Saing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakez","family":"Kayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dahlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Broadwater-Hollifield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Mobley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Lott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Doran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford","family":"Anderson-Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Cribbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Glabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,4,10]]},"reference":[{"issue":"1\u20132","key":"530_CR1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-3940(99)00009-9","volume":"261","author":"RA Armstrong","year":"1999","unstructured":"Armstrong RA (1999) Do beta-amyloid (Abeta) deposits in patients with Alzheimer\u2019s disease and Down\u2019s syndrome grow according to the log-normal model? Neurosci Lett 261(1\u20132):97\u2013100. doi: 10.1016\/S0304-3940(99)00009-9","journal-title":"Neurosci Lett"},{"key":"530_CR2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1192\/bjp.114.512.797","volume":"114","author":"G Blessed","year":"1968","unstructured":"Blessed G, Tomlinson BE, Roth M (1968) The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114:797\u2013811. doi: 10.1192\/bjp.114.512.797","journal-title":"Br J Psychiatry"},{"issue":"16","key":"530_CR3","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1523\/JNEUROSCI.4814-07.2008","volume":"28","author":"T Bolmont","year":"2008","unstructured":"Bolmont T, Haiss F, Eicke D, Radde R, Mathis CA, Klunk WE et al (2008) Dynamics of the microglial\/amyloid interaction indicate a role in plaque maintenance. J Neurosci 28(16):4283\u20134292. doi: 10.1523\/JNEUROSCI.4814-07.2008","journal-title":"J Neurosci"},{"issue":"Pt 3","key":"530_CR4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2818.2006.01706.x","volume":"224","author":"S Bolte","year":"2006","unstructured":"Bolte S, Cordelieres FP (2006) A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224(Pt 3):213\u2013232. doi: 10.1111\/j.1365-2818.2006.01706.x","journal-title":"J Microsc"},{"issue":"4","key":"530_CR5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4):239\u2013259. doi: 10.1007\/BF00308809","journal-title":"Acta Neuropathol"},{"issue":"3","key":"530_CR6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","volume":"16","author":"H Braak","year":"1995","unstructured":"Braak H, Braak E (1995) Staging of Alzheimer\u2019s disease-related neurofibrillary changes. Neurobiol Aging 16(3):271\u2013284. doi: 10.1016\/0197-4580(95)00021-6","journal-title":"Neurobiol Aging"},{"key":"530_CR7","first-page":"403","volume":"33","author":"H Braak","year":"1993","unstructured":"Braak H, Braak E, Bohl J (1993) Staging of Alzheimer-related cortical destruction. Rev Clin Neurosci 33:403\u2013408","journal-title":"Rev Clin Neurosci"},{"issue":"2","key":"530_CR8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1352\/0895-8017(2004)109<83:RFFDIP>2.0.CO;2","volume":"109","author":"A Bush","year":"2004","unstructured":"Bush A, Beail N (2004) Risk factors for dementia in people with Down syndrome: issues in assessment and diagnosis. Am J Ment Retard 109(2):83\u201397. doi: 10.1352\/0895-8017(2004)109<83:RFFDIP>2.0.CO;2","journal-title":"Am J Ment Retard"},{"key":"530_CR9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","volume":"26","author":"B Caughey","year":"2003","unstructured":"Caughey B, Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26:267\u2013298. doi: 10.1146\/annurev.neuro.26.010302.081142","journal-title":"Annu Rev Neurosci"},{"issue":"1","key":"530_CR10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2008.02.003","volume":"58","author":"JR Cirrito","year":"2008","unstructured":"Cirrito JR, Kang JE, Lee J, Stewart FR, Verges DK, Silverio LM et al (2008) Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron 58(1):42\u201351. doi: 10.1016\/j.neuron.2008.02.003","journal-title":"Neuron"},{"issue":"5","key":"530_CR11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1101\/lm.51002","volume":"9","author":"KA Corcoran","year":"2002","unstructured":"Corcoran KA, Lu Y, Turner RS, Maren S (2002) Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer\u2019s disease. Learn Mem 9(5):243\u2013252. doi: 10.1101\/lm.51002","journal-title":"Learn Mem"},{"issue":"4","key":"530_CR12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0197-4580(97)00049-3","volume":"18","author":"BJ Cummings","year":"1997","unstructured":"Cummings BJ (1997) Plaques and tangles: searching for primary events in a forest of data. Neurobiol Aging 18(4):358\u2013362. doi: 10.1016\/S0197-4580(97)00049-3","journal-title":"Neurobiol Aging"},{"key":"530_CR13","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/S0140-6736(95)92053-6","volume":"346","author":"BJ Cummings","year":"1995","unstructured":"Cummings BJ, Cotman CW (1995) Image analysis of beta-amyloid \u201cload\u201d in Alzheimer\u2019s disease and relation to dementia severity. Lancet 346:1524\u20131528. doi: 10.1016\/S0140-6736(95)92053-6","journal-title":"Lancet"},{"issue":"6","key":"530_CR14","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0197-4580(96)00170-4","volume":"17","author":"BJ Cummings","year":"1996","unstructured":"Cummings BJ, Pike CJ, Shankle R, Cotman CW (1996) Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer\u2019s disease. Neurobiol Aging 17(6):921\u2013933. doi: 10.1016\/S0197-4580(96)00170-4","journal-title":"Neurobiol Aging"},{"issue":"4","key":"530_CR15","first-page":"653","volume":"17","author":"BJ Cummings","year":"1996","unstructured":"Cummings BJ, Satou T, Head E, Milgram NW, Cole GM, Savage MJ et al (1996) Diffuse plaques contain C-terminal A beta 42 and not A beta 40: evidence from cats and dogs. Neurobiol Aging 17(4):653\u2013659","journal-title":"Neurobiol Aging"},{"issue":"6","key":"530_CR16","first-page":"1594","volume":"143","author":"CA Davies","year":"1993","unstructured":"Davies CA, Mann DMA (1993) Is the \u201cPreamyloid\u201d of diffuse plaques in Alzheimer\u2019s disease really nonfibrillar? Am J Pathol 143(6):1594\u20131605","journal-title":"Am J Pathol"},{"issue":"4","key":"530_CR17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/archneur.64.4.541","volume":"64","author":"ST DeKosky","year":"2007","unstructured":"DeKosky ST, Abrahamson EE, Ciallella JR, Paljug WR, Wisniewski SR, Clark RS et al (2007) Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans. Arch Neurol 64(4):541\u2013544. doi: 10.1001\/archneur.64.4.541","journal-title":"Arch Neurol"},{"issue":"22","key":"530_CR18","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1523\/JNEUROSCI.1189-06.2006","volume":"26","author":"A Deshpande","year":"2006","unstructured":"Deshpande A, Mina E, Glabe C, Busciglio J (2006) Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci 26(22):6011\u20136018. doi: 10.1523\/JNEUROSCI.1189-06.2006","journal-title":"J Neurosci"},{"issue":"4","key":"530_CR19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005072-199704000-00001","volume":"56","author":"DW Dickson","year":"1997","unstructured":"Dickson DW (1997) The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56(4):321\u2013339. doi: 10.1097\/00005072-199704000-00001","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"530_CR20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0197-4580(95)00013-5","volume":"16","author":"DW Dickson","year":"1995","unstructured":"Dickson DW, Crystal HA, Bevona C, Honer W, Vincent I, Davies P (1995) Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging 16(3):285\u2013304. doi: 10.1016\/0197-4580(95)00013-5","journal-title":"Neurobiol Aging"},{"key":"530_CR21","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/382716a0","volume":"382","author":"J El Khoury","year":"1996","unstructured":"El Khoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD (1996) Scavenger receptor mediated adhesion of microglia to beta-amyloid fibrils. Nature 382:716\u2013719. doi: 10.1038\/382716a0","journal-title":"Nature"},{"key":"530_CR22","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0197-4580(98)00036-0","volume":"19","author":"J El Khoury","year":"1998","unstructured":"El Khoury J, Hickman SE, Thomas CA, Loike JD, Sliverstein SC (1998) Microglia, scavenger receptors and the pathogenesis of Alzheimer\u2019s disease. Neurobiol Aging 19:S81. doi: 10.1016\/S0197-4580(98)00036-0","journal-title":"Neurobiol Aging"},{"issue":"9","key":"530_CR23","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","volume":"60","author":"P Giannakopoulos","year":"2003","unstructured":"Giannakopoulos P, Herrmann FR, Bussiere T, Bouras C, Kovari E, Perl DP et al (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer\u2019s disease. Neurology 60(9):1495\u20131500","journal-title":"Neurology"},{"issue":"4","key":"530_CR24","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.neurobiolaging.2005.04.017","volume":"27","author":"CG Glabe","year":"2006","unstructured":"Glabe CG (2006) Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol Aging 27(4):570\u2013575. doi: 10.1016\/j.neurobiolaging.2005.04.017","journal-title":"Neurobiol Aging"},{"key":"530_CR25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer\u2019s disease and Down\u2019s syndrome sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 120:885\u2013890. doi: 10.1016\/S0006-291X(84)80190-4","journal-title":"Biochem Biophys Res Commun"},{"key":"530_CR26","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1074\/jbc.270.13.7013","volume":"270","author":"SA Gravina","year":"1995","unstructured":"Gravina SA, Ho L, Eckman CB, Long KE, Otvos L, Younkin LH, Suzuki N, Younkin SG (1995) Amyloid \u03b2-protein (A\u03b2) in Alzheimer\u2019s disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms of A\u03b2(40) and A\u03b242(43). J Biol Chem 270:7013\u20137016. doi: 10.1074\/jbc.270.13.7013","journal-title":"J Biol Chem"},{"issue":"5580","key":"530_CR27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297(5580):353\u2013356. doi: 10.1126\/science.1072994","journal-title":"Science"},{"issue":"2","key":"530_CR28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1074-5521(97)90255-6","volume":"4","author":"JD Harper","year":"1997","unstructured":"Harper JD, Wong SS, Lieber CM, Lansbury PT (1997) Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. Chem Biol 4(2):119\u2013125. doi: 10.1016\/S1074-5521(97)90255-6","journal-title":"Chem Biol"},{"key":"530_CR29","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1006\/nbdi.2001.0431","volume":"8","author":"E Head","year":"2001","unstructured":"Head E, Garzon-Rodriguez W, Johnson JK, Lott IT, Cotman CW, Glabe C (2001) Oxidation of A\u03b2 and plaque biogenesis in Alzheimer\u2019s disease and Down syndrome. Neurobiol Dis 8:792\u2013806. doi: 10.1006\/nbdi.2001.0431","journal-title":"Neurobiol Dis"},{"key":"530_CR30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archneur.1995.00540280065020","volume":"52","author":"PR Hof","year":"1995","unstructured":"Hof PR, Bouras C, Perl DP, Sparks DL, Mehta N, Morrison JH (1995) Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down\u2019s syndrome. Arch Neurol 52:379\u2013391","journal-title":"Arch Neurol"},{"key":"530_CR31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsaio","year":"1996","unstructured":"Hsaio K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Ab elevation, and amyloid plaques in transgenic mice. Science 274:99\u2013102. doi: 10.1126\/science.274.5284.99","journal-title":"Science"},{"issue":"3","key":"530_CR32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ana.410370305","volume":"37","author":"T Iwatsubo","year":"1995","unstructured":"Iwatsubo T, Mann DM, Odaka A, Suzuki N, Ihara Y (1995) Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome. Ann Neurol 37(3):294\u2013299. doi: 10.1002\/ana.410370305","journal-title":"Ann Neurol"},{"issue":"6106","key":"530_CR33","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/325733a0","volume":"325","author":"J Kang","year":"1987","unstructured":"Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH et al (1987) The precursor of Alzheimer\u2019s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325(6106):733\u2013736. doi: 10.1038\/325733a0","journal-title":"Nature"},{"issue":"2","key":"530_CR34","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","volume":"21","author":"T Kawarabayashi","year":"2001","unstructured":"Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG (2001) Age-dependent changes in brain, CSF, and plasma amyloid \u03b2 protein in the Tg2576 transgenic mouse model of Alzheimer\u2019s disease. J Neurosci 21(2):372\u2013381","journal-title":"J Neurosci"},{"key":"530_CR35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-2-18","volume":"2","author":"R Kayed","year":"2007","unstructured":"Kayed R, Head E, Sarsoza F, Saing T, Cotman CW, Necula M et al (2007) Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener 2:18. doi: 10.1186\/1750-1326-2-18","journal-title":"Mol Neurodegener"},{"key":"530_CR36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW et al (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486\u2013489. doi: 10.1126\/science.1079469","journal-title":"Science"},{"key":"530_CR37","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archneur.1985.04060100083029","volume":"42","author":"ZS Khachaturian","year":"1985","unstructured":"Khachaturian ZS (1985) Diagnosis of Alzheimer\u2019s disease. Arch Neurol 42:1097\u20131106","journal-title":"Arch Neurol"},{"issue":"2","key":"530_CR38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0166-4328(99)00037-6","volume":"103","author":"DL King","year":"1999","unstructured":"King DL, Arendash GW, Crawford F, Sterk T, Menendez J, Mullan MJ (1999) Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer\u2019s disease. Behav Brain Res 103(2):145\u2013162. doi: 10.1016\/S0166-4328(99)00037-6","journal-title":"Behav Brain Res"},{"issue":"2","key":"530_CR39","first-page":"230","volume":"57","author":"T Kitamoto","year":"1987","unstructured":"Kitamoto T, Ogomori K, Tateishi J, Prusiner SB (1987) Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 57(2):230\u2013236","journal-title":"Lab Invest"},{"issue":"18","key":"530_CR40","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1093\/hmg\/9.18.2589","volume":"9","author":"S Kumar-Singh","year":"2000","unstructured":"Kumar-Singh S, De Jonghe C, Cruts M, Kleinert R, Wang R, Mercken M et al (2000) Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer\u2019s disease. Hum Mol Genet 9(18):2589\u20132598. doi: 10.1093\/hmg\/9.18.2589","journal-title":"Hum Mol Genet"},{"key":"530_CR41","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archneur.1989.00520440031017","volume":"46","author":"F Lai","year":"1989","unstructured":"Lai F, Williams MD (1989) A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 46:849\u2013853","journal-title":"Arch Neurol"},{"key":"530_CR42","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M et al (1998) Diffusible, nonfibrillar ligands derived from A\u03b21\u201342 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448\u20136453. doi: 10.1073\/pnas.95.11.6448","journal-title":"Proc Natl Acad Sci USA"},{"key":"530_CR43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/nbdi.1996.0003","volume":"3","author":"CA Lemere","year":"1996","unstructured":"Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ (1996) Sequence of deposition of heterogeneous amyloid beta-peptides and APOE in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis 3:16\u201332. doi: 10.1006\/nbdi.1996.0003","journal-title":"Neurobiol Dis"},{"issue":"7082","key":"530_CR44","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","volume":"440","author":"S Lesne","year":"2006","unstructured":"Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A et al (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440(7082):352\u2013357. doi: 10.1038\/nature04533","journal-title":"Nature"},{"key":"530_CR45","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/exnr.1997.6777","volume":"150","author":"JB Leverenz","year":"1998","unstructured":"Leverenz JB, Raskind MA (1998) Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: a regional quantitative analysis. Exp Neurol 150:296\u2013304. doi: 10.1006\/exnr.1997.6777","journal-title":"Exp Neurol"},{"issue":"3","key":"530_CR46","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/mrdd.1025","volume":"7","author":"IT Lott","year":"2001","unstructured":"Lott IT, Head E (2001) Down syndrome and Alzheimer\u2019s disease: a link between development and aging. Ment Retard Dev Disabil Res Rev 7(3):172\u2013178. doi: 10.1002\/mrdd.1025","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"530_CR47","first-page":"21","volume-title":"Neurodegeneration","author":"DM Mann","year":"1992","unstructured":"Mann DM (1992) Down syndrome and Alzheimer\u2019s disease: towards an understanding of pathogenesis. In: Hunter AJ, Clarke S (eds) Neurodegeneration. Academic Press, San Diego, pp 21\u201331"},{"issue":"3","key":"530_CR48","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2990.1988.tb00880.x","volume":"14","author":"DM Mann","year":"1988","unstructured":"Mann DM, Marcyniuk B, Yates PO, Neary D, Snowden JS (1988) The progression of the pathological changes of Alzheimer\u2019s disease in frontal and temporal neocortex examined both at biopsy and at autopsy. Neuropathol Appl Neurobiol 14(3):177\u2013195. doi: 10.1111\/j.1365-2990.1988.tb00880.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"530_CR49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0047-6374(88)90041-3","volume":"43","author":"DMA Mann","year":"1988","unstructured":"Mann DMA (1988) The pathological association between Down syndrome and Alzheimer disease. Mech Ageing Dev 43:99\u2013136. doi: 10.1016\/0047-6374(88)90041-3","journal-title":"Mech Ageing Dev"},{"key":"530_CR50","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0022-510X(89)90019-1","volume":"89","author":"DMA Mann","year":"1989","unstructured":"Mann DMA, Esiri MM (1989) The pattern of acquisition of plaques and tangles in the brains of patients under 50\u00a0years of age with Down\u2019s syndrome. J Neurol Sci 89:169\u2013179. doi: 10.1016\/0022-510X(89)90019-1","journal-title":"J Neurol Sci"},{"issue":"6","key":"530_CR51","first-page":"1293","volume":"137","author":"E Masliah","year":"1990","unstructured":"Masliah E, Terry RD, Mallory M, Alford M, Hansen LA (1990) Diffuse plaques do not accentuate synapse loss in Alzheimer\u2019s disease. Am J Pathol 137(6):1293\u20131297","journal-title":"Am J Pathol"},{"key":"530_CR52","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ana.410300206","volume":"30","author":"AC McKee","year":"1991","unstructured":"McKee AC, Kosik KS, Kowall NW (1991) Neuritic pathology and dementia in Alzheimer\u2019s disease. Ann Neurol 30:156\u2013165. doi: 10.1002\/ana.410300206","journal-title":"Ann Neurol"},{"issue":"4","key":"530_CR53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41(4):479\u2013486","journal-title":"Neurology"},{"issue":"6815","key":"530_CR54","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/35050116","volume":"408","author":"D Morgan","year":"2000","unstructured":"Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J et al (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer\u2019s disease. Nature 408(6815):982\u2013985. doi: 10.1038\/35050116","journal-title":"Nature"},{"issue":"4","key":"530_CR55","first-page":"641","volume":"24","author":"JC Morris","year":"1988","unstructured":"Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A (1988) Consortium to establish a registry for Alzheimer\u2019s disease (CERAD) clinical and neuropsychological assessment of Alzheimer\u2019s disease. Psychopharmacol Bull 24(4):641\u2013652","journal-title":"Psychopharmacol Bull"},{"issue":"3","key":"530_CR56","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1212\/WNL.46.3.707","volume":"46","author":"JC Morris","year":"1996","unstructured":"Morris JC, Storandt M, McKeel DW Jr, Rubin EH, Price JL, Grant EA et al (1996) Cerebral amyloid deposition and diffuse plaques in \u201cnormal\u201d aging: evidence for presymptomatic and very mild Alzheimer\u2019s disease. Neurology 46(3):707\u2013719","journal-title":"Neurology"},{"issue":"3","key":"530_CR57","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archneur.58.3.397","volume":"58","author":"JC Morris","year":"2001","unstructured":"Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH et al (2001) Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 58(3):397\u2013405. doi: 10.1001\/archneur.58.3.397","journal-title":"Arch Neurol"},{"issue":"12","key":"530_CR58","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/nen.0b013e31815c5efb","volume":"66","author":"PT Nelson","year":"2007","unstructured":"Nelson PT, Jicha GA, Schmitt FA, Liu H, Davis DG, Mendiondo MS et al (2007) Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles \u201cdo count\u201d when staging disease severity. J Neuropathol Exp Neurol 66(12):1136\u20131146. doi: 10.1097\/nen.0b013e31815c5efb","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"530_CR59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0197-4580(96)00207-2","volume":"18","author":"C Pallister","year":"1997","unstructured":"Pallister C, Jung SS, Shaw I, Nalbantoglu J, Gauthier S, Cashman NR (1997) Lymphocyte content of amyloid precursor protein is increased in Down\u2019s syndrome and aging. Neurobiol Aging 18(1):97\u2013103. doi: 10.1016\/S0197-4580(96)00207-2","journal-title":"Neurobiol Aging"},{"issue":"46","key":"530_CR60","doi-asserted-by":"crossref","first-page":"29390","DOI":"10.1074\/jbc.272.46.29390","volume":"272","author":"DM Paresce","year":"1997","unstructured":"Paresce DM, Chung H, Maxfield FR (1997) Slow degradation of aggregates of the Alzheimer\u2019s disease amyloid \u03b2-protein by microglial cells. J Biol Chem 272(46):29390\u201329397. doi: 10.1074\/jbc.272.46.29390","journal-title":"J Biol Chem"},{"key":"530_CR61","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0896-6273(00)80187-7","volume":"17","author":"DM Paresce","year":"1996","unstructured":"Paresce DM, Gosh R, Maxfield FR (1996) Microglial cells internalize aggregates of the Alzheimer\u2019s disease amyloid \u03b2-protein via a scavenger receptor. Neuron 17:553\u2013565. doi: 10.1016\/S0896-6273(00)80187-7","journal-title":"Neuron"},{"issue":"3","key":"530_CR62","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"RC Petersen","year":"1999","unstructured":"Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56(3):303\u2013308. doi: 10.1001\/archneur.56.3.303","journal-title":"Arch Neurol"},{"issue":"Pt. 5","key":"530_CR63","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2788.1995.tb00547.x","volume":"39","author":"VP Prasher","year":"1995","unstructured":"Prasher VP, Filer A (1995) Behavioural disturbance in people with Down\u2019s syndrome and dementia. J Intellect Disabil Res 39(Pt. 5):432\u2013436","journal-title":"J Intellect Disabil Res"},{"key":"530_CR64","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1056\/NEJM198906013202203","volume":"320","author":"B Rumble","year":"1989","unstructured":"Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R et al (1989) Amyloid A4 and its precursor in Down\u2019s syndrome and Alzheimer\u2019s disease. N Engl J Med 320:1446\u20131462","journal-title":"N Engl J Med"},{"key":"530_CR65","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","volume":"400","author":"D Schenk","year":"1999","unstructured":"Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandervert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P (1999) Immunization with amyloid-\u03b2 attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173\u2013177. doi: 10.1038\/22124","journal-title":"Nature"},{"issue":"4","key":"530_CR66","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R et al (1991) Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30(4):572\u2013580. doi: 10.1002\/ana.410300410","journal-title":"Ann Neurol"},{"issue":"S4","key":"530_CR67","first-page":"1","volume":"18","author":"The National Institute on Aging aRIWGoDCftNAoAsd","year":"1997","unstructured":"The National Institute on Aging aRIWGoDCftNAoAsd (1997) Consensus recommendations for the post mortem diagnosis of Alzheimer\u2019s disease. Neurobiol Aging 18(S4):1\u20132","journal-title":"Neurobiol Aging"},{"issue":"3","key":"530_CR68","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0306-4522(99)00568-0","volume":"93","author":"R Torp","year":"2000","unstructured":"Torp R, Head E, Milgram NW, Hahn F, Ottersen OP, Cotman CW (2000) Ultrastructural evidence of fibrillar \u03b2-amyloid associated with neuronal membranes in behaviorally characterized aged dog brains. Neuroscience 93(3):495\u2013506. doi: 10.1016\/S0306-4522(99)00568-0","journal-title":"Neuroscience"},{"issue":"12","key":"530_CR69","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/gps.502","volume":"16","author":"J Tyrrell","year":"2001","unstructured":"Tyrrell J, Cosgrave M, McCarron M, McPherson J, Calvert J, Kelly A et al (2001) Dementia in people with Down\u2019s syndrome. Int J Geriatr Psychiatry 16(12):1168\u20131174. doi: 10.1002\/gps.502","journal-title":"Int J Geriatr Psychiatry"},{"issue":"36","key":"530_CR70","doi-asserted-by":"crossref","first-page":"25945","DOI":"10.1074\/jbc.274.36.25945","volume":"274","author":"DM Walsh","year":"1999","unstructured":"Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, Lomakin A et al (1999) Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem 274(36):25945\u201325952. doi: 10.1074\/jbc.274.36.25945","journal-title":"J Biol Chem"},{"issue":"6880","key":"530_CR71","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS et al (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416(6880):535\u2013539. doi: 10.1038\/416535a","journal-title":"Nature"},{"key":"530_CR72","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00495299","volume":"83","author":"B Wang","year":"1985","unstructured":"Wang B, Larson L (1985) Simultaneous demonstration of multiple antigens by indirect immunofluorescence or immunogold staining. Histochemistry 83:47\u201356. doi: 10.1007\/BF00495299","journal-title":"Histochemistry"},{"issue":"5","key":"530_CR73","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1523\/JNEUROSCI.22-05-01858.2002","volume":"22","author":"MA Westerman","year":"2002","unstructured":"Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, Younkin LH, Carlson GA, Younkin SG, Ashe KH (2002) The relationship between A\u03b2 and memory in the Tg2576 mouse model of Alzheimer\u2019s disease. J Neurosci 22(5):1858\u20131867","journal-title":"J Neurosci"},{"key":"530_CR74","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2307\/1912934","volume":"48","author":"H White","year":"1980","unstructured":"White H (1980) A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 48:817\u2013830. doi: 10.2307\/1912934","journal-title":"Econometrica"},{"issue":"20","key":"530_CR75","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.1073\/pnas.0408582102","volume":"102","author":"AD Williams","year":"2005","unstructured":"Williams AD, Sega M, Chen M, Kheterpal I, Geva M, Berthelier V et al (2005) Structural properties of A beta protofibrils stabilized by a small molecule. Proc Natl Acad Sci USA 102(20):7115\u20137120. doi: 10.1073\/pnas.0408582102","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"530_CR76","first-page":"619","volume":"13","author":"K Wisniewski","year":"1978","unstructured":"Wisniewski K, Howe J, Williams G, Wisniewski HM (1978) Precocious aging and dementia in patients with Down\u2019s syndrome. Biol Psychiatry 13(5):619\u2013627","journal-title":"Biol Psychiatry"},{"key":"530_CR77","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ana.410170310","volume":"17","author":"K Wisniewski","year":"1985","unstructured":"Wisniewski K, Wisniewski H, Wen G (1985) Occurrence of neuropathological changes and dementia of Alzheimer\u2019s disease in Down\u2019s syndrome. Ann Neurol 17:278\u2013282. doi: 10.1002\/ana.410170310","journal-title":"Ann Neurol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-009-0530-3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,7]],"date-time":"2019-04-07T05:00:35Z","timestamp":1554613235000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-009-0530-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,10]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["530"],"URL":"https:\/\/doi.org\/10.1007\/s00401-009-0530-3","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,10]]}}}